Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
01 1Chunghwa Chemical Synthesis & Biotech. Ltd
01 1MYCOPHENOLATE MOFETIL HYDROCHLORIDE ANHYDROUS
01 1Taiwan
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
NDC Package Code : 52076-6235
Start Marketing Date : 2018-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
A Mycophenolate Mofetil Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mycophenolate Mofetil Hydrochloride, including repackagers and relabelers. The FDA regulates Mycophenolate Mofetil Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mycophenolate Mofetil Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mycophenolate Mofetil Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mycophenolate Mofetil Hydrochloride supplier is an individual or a company that provides Mycophenolate Mofetil Hydrochloride active pharmaceutical ingredient (API) or Mycophenolate Mofetil Hydrochloride finished formulations upon request. The Mycophenolate Mofetil Hydrochloride suppliers may include Mycophenolate Mofetil Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Mycophenolate Mofetil Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mycophenolate Mofetil Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mycophenolate Mofetil Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mycophenolate Mofetil Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mycophenolate Mofetil Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mycophenolate Mofetil Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mycophenolate Mofetil Hydrochloride suppliers with NDC on PharmaCompass.
We have 1 companies offering Mycophenolate Mofetil Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
